Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exp... von Krop, I.E., Lin, N.U., Blackwell, K., Guardino, E., Huober, J., Lu, M., Miles, D., Samant, M., Welslau, M., Diéras, V.

Volltext

PIK3CA mutations in HER2-positive breast cancer: an ongoing conundrum von Goel, S., Krop, I.E.

Volltext

Classroom ventilation and indoor air quality-results from the FRESH intervention study von Rosbach, J., Krop, E., Vonk, M., van Ginkel, J., Meliefste, C., de Wind, S., Gehring, U., Brunekreef, B.

Volltext

Lessons from breast cancer trials of HER2-kinase inhibitors von Krop, Ian E

Volltext

Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall... von Diéras, Véronique, Dr, Miles, David, Prof, Verma, Sunil, MD, Pegram, Mark, Prof, Welslau, Manfred, MD, Baselga, José, MD, Krop, Ian E, MD, Blackwell, Kim, Prof, Hoersch, Silke, MSc, Xu, Jin, PhD, Green, Marjorie, MD, Gianni, Luca, MD

Volltext

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes von Tung, Nadine M., Robson, Mark E., Ventz, Steffen, Santa-Maria, Cesar A., Nanda, Rita, Marcom, Paul K., Shah, Payal D., Ballinger, Tarah J., Yang, Eddy S., Vinayak, Shaveta, Melisko, Michelle, Brufsky, Adam, DeMeo, Michelle, Jenkins, Colby, Domchek, Susan, D'Andrea, Alan, Lin, Nancy U., Hughes, Melissa E., Carey, Lisa A., Wagle, Nick, Wulf, Gerburg M., Krop, Ian E., Wolff, Antonio C., Winer, Eric P., Garber, Judy E.

Volltext

Deciphering the role of phosphatidylinositol 3-kinase mutations in human epidermal growth factor receptor 2-positive breast cancer von Goel, Shom, Krop, Ian E

Volltext

Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results fr... von Krop, Ian E, Dr, Kim, Sung-Bae, Prof, Martin, Antonio Gonzalez, MD, LoRusso, Patricia M, Prof, Ferrero, Jean-Marc, MD, Badovinac-Crnjevic, Tanja, MD, Hoersch, Silke, MSc, Smitt, Melanie, MD, Wildiers, Hans, Prof

Volltext

IN04 OPTIMAL MANAGEMENT OF HER-2+ ABC von Krop, Ian E

Volltext

Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer von Barroso-Sousa, Romualdo, Keenan, Tanya E., Pernas, Sonia, Exman, Pedro, Jain, Esha, Garrido-Castro, Ana C., Hughes, Melissa, Bychkovsky, Brittany, Umeton, Renato, Files, Janet L., Lindeman, Neal I., MacConaill, Laura E., Hodi, F. Stephen, Krop, Ian E., Dillon, Deborah, Winer, Eric P., Wagle, Nikhil, Lin, Nancy U., Mittendorf, Elizabeth A., Van Allen, Eliezer M., Tolaney, Sara M.

Volltext

Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies von MAYER, Erica L, KROP, Ian E

Volltext

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial von Krop, Ian E, Dr, Kim, Sung-Bae, Prof, González-Martín, Antonio, MD, LoRusso, Patricia M, Prof, Ferrero, Jean-Marc, Prof, Smitt, Melanie, MD, Yu, Ron, PhD, Leung, Abraham C F, MD, Wildiers, Hans, Prof

Volltext

Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update von Ramakrishna, Naren, Anders, Carey K, Lin, Nancy U, Morikawa, Aki, Temin, Sarah, Chandarlapaty, Sarat, Crews, Jennie R, Davidson, Nancy E, Franzoi, Maria Alice B, Kirshner, Jeffrey J, Krop, Ian E, Patt, Debra A, Perlmutter, Jane, Giordano, Sharon H

Volltext

A Phase II Study of Trastuzumab Emtansine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab,... von KROP, Ian E, LORUSSO, Patricia, AMLER, Lukas, WINER, Eric P, RUGO, Hope S, MILLER, Kathy D, MODI, Shanu, YARDLEY, Denise, RODRIGUEZ, Gladys, GUARDINO, Ellie, LU, Michael, MAOXIA ZHENG, GIRISH, Sandhya

Volltext

Trastuzumab: qui bono? von Krop, Ian E, Burstein, Harold J

Volltext

Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients von Tolaney, Sara M., Boucher, Yves, Duda, Dan G., Martin, John D., Seano, Giorgio, Ancukiewicz, Marek, Barry, William T., Goel, Shom, Lahdenrata, Johanna, Isakoff, Steven J., Yeh, Eren D., Jain, Saloni R., Golshan, Mehra, Brock, Jane, Snuderl, Matija, Winer, Eric P., Krop, Ian E., Jain, Rakesh K.

Volltext

Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed... von BURRIS, Howard A, RUGO, Hope S, AMLER, Lukas, MAOXIA ZHENG, CHU, Yu-Waye, KLENCKE, Barbara, O'SHAUGHNESSY, Joyce A, VUKELJA, Svetislava J, VOGEL, Charles L, BORSON, Rachel A, LIMENTANI, Steven, TAN-CHIU, Elizabeth, KROP, Ian E, MICHAELSON, Richard A, GIRISH, Sandhya

Volltext

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer von Garrido-Castro, Ana C., Saura, Cristina, Barroso-Sousa, Romualdo, Guo, Hao, Ciruelos, Eva, Bermejo, Begona, Gavila, Joaquin, Serra, Violeta, Prat, Aleix, Pare, Laia, Celiz, Pamela, Villagrasa, Patricia, Li, Yisheng, Savoie, Jennifer, Xu, Zhan, Arteaga, Carlos L., Krop, Ian E., Solit, David B., Mills, Gordon B., Cantley, Lewis C., Winer, Eric P., Lin, Nancy U., Rodon, Jordi

Volltext

Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 tri... von Krop, Ian E, Dr, Mayer, Ingrid A, MD, Ganju, Vinod, FRACP, Dickler, Maura, MD, Johnston, Stephen, MD, Morales, Serafin, MD, Yardley, Denise A, MD, Melichar, Bohuslav, Prof, Forero-Torres, Andres, MD, Lee, Soo Chin, MRCP, de Boer, Richard, FRACP, Petrakova, Katarina, PhD, Vallentin, Susanne, MD, Perez, Edith A, MD, Piccart, Martine, Prof, Ellis, Matthew, Prof, Winer, Eric, Prof, Gendreau, Steven, PhD, Derynck, Mika, MD, Lackner, Mark, PhD, Levy, Gallia, MD, Qiu, Jiaheng, PhD, He, Jing, MD, Schmid, Peter, Prof

Volltext

A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer von Lin, N. U., Seah, D. S., Gelman, R., Desantis, S., Mayer, E. L., Isakoff, S., DiPiro, P., Krop, I. E., Come, S. E., Weckstein, D., Winer, E. P., Burstein, H. J.

Volltext